Isatuximab–dexamethasone–pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 12, p. 2087, doi. 10.1002/psp4.13206
- By:
- Publication type:
- Article